187
Views
15
CrossRef citations to date
0
Altmetric
Review Article

Pathology Working Group review and evaluation of proliferative lesions of mammary gland tissues in female rats fed ammonium perfluorooctanoate (APFO) in the diet for 2 years

, , , , , , & show all
Pages 131-137 | Received 15 Dec 2009, Accepted 01 Feb 2010, Published online: 22 Mar 2010

References

  • Alexander, B. H., Olsen, G. W., Burris, J. M., Mandel, J. H., Mandel, J. S. (2003). Mortality study of employees of a perflurooctanesulphonyl fluoride manufacturing plant. Occup Environ Med 60:722–729.
  • Alexander, B, H., Olsen, G. W. (2007). Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann Epidemiol 17:471–478.
  • Barber, J. L., Berger, U., Chaemfa, C., Huber, S., Jahnke, A., Temme, C., et al. (2007). Analysis of per- and polyfluorinated alkyl substances in air samples from Northwest Europe. J Environ Monit 9:530–541.
  • Bartell, S. M., Calafat, A. M., Lyu, C., Kato, K., Ryan, P. B., Steenland, K. (2010). Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 118:222–228.
  • Biegel, L. B., Hurtt, M. E., Frame, S. R., O’Connor, J. C., Cook, J. C. (2001). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 60:44–55.
  • Butenhoff, J. L., Kennedy, G. L., Jr., Frame, S. R., O’Connor, J. C., York, R. G. (2004). The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196:95–116.
  • Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A., Needham, L. L. (2007). Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons to NHANES 1999–2000. Environ Health Perspect 11:1596–1602.
  • Chandra, M., Riley, M. G., Johnson, D. E. (1992). Spontaneous neoplasms in aged Sprague-Dawley rats. Arch Toxicol 66:496–502.
  • Emmett, E. A., Shofer, F. S., Zhang, H., Freeman, D., Desai, C., Shaw, L. M. (2006). Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48:759–770.
  • Eriksen, K. T., Sorenson, M., McLaughlin, J. K., Lipworth, L., Tjonneland, A., Overvad, K. (2009). Perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 101:605–609.
  • Fisher, R. A., (1950). Statistical methods for research workers. Edinburgh, UK: Oliver and Boyd.
  • Giknis, M. L. A., Clifford, C. B. (2001). Compilation of spontaneous neoplastic lesions and survival in Crl:CDR (SD) rats from control groups. Charles River Laboratories.
  • Giknis, M. L. A., Clifford, C. B. (2004). Compilation of spontaneous neoplastic lesions and survival in Crl:CDR (SD) rats from control groups. Charles River Laboratories.
  • Houde, M., Martin, J. W., Solomon, K. R., Muir, D. C. (2006). Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 40:3463–3473.
  • Inveresk Research. (2002). Background tumour incidences CD Sprague-Dawley rats. Inveresk Research.
  • Kennedy, G. L., Jr., Butenhoff, J. L., Olsen, G. W., O’Connor, J. C., Seacat, A. M., Perkins, R. G., et al. (2004). The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384.
  • Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., Seed, J. (2007). Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394.
  • Leonard, R. C., Kreckmann, K. H., Sakr, C. J., Symons, J. M. (2008). Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18:15–22.
  • Loos, R., Gawlik, B. M., Locoro, G., Rimaviciute, E., Contini, S., Bidoglio, G. (2009). EU-wide survey of polar organic persistent pollutants in European river waters. Environ Pollut 157:561–568.
  • Lundin, J. I., Alexander, B. H., Olsen, G. W., Church, T. R. (2009). Mortality of employees of an ammonium perfluorooctanoate production facility. Epidemiology 20:921–928.
  • McConnell, E. E., Solleveld, H. A., Swenberg, J. A., Boorman, G. A. (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J Natl Cancer Inst 76:283–289.
  • McMartin, D. N., Sahota, P. S., Gunson, D. E., Hsu, H. H., Spaet, R. H. (1992). Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies. Historical data and diagnostic considerations. Toxicol Pathol 20:212–225.
  • Mann, P. C., Boorman, G. A., Lollini, L. O., McMartin, D. N., Goodman, D. G. (1996). Proliferative lesions of the mammary gland in rats, IS-2 in Guides for Toxicologic Pathology. Washington, DC: STP/ARP/AFIP.
  • Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L. (2007). Half-life of serum elimination of perfluorooctanesulfonate, perfluoroohexane sulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298–1305.
  • Olsen, G. W., Mair, D. C., Church, T. R., Ellefson, M. E., Reagen, W. K., Boyd, T. A., et al. (2008). Decline in PFOS and other perfluoroalkyl chemicals in American Red Cross adult blood donors. Environ Sci Technol 42:4989–4995.
  • Olsen, G. W., Butenhoff, J. W., Zobel, L. R. (2009). Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 27:212–230.
  • Portier, C. J., Bailer, A. J. (1989). Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam Appl Toxicol 12:731–737.
  • Rudel, R. A., Attfield, K. R., Schifano, J. N., Brody, J. G. (2007). Chemicals causing mammary gland tumors in animals signals new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer Suppl 109:2635–2366.
  • Russo, J., Russo, H. R. (1996). Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 39:7–20.
  • Sakr, C. J., Kreckmann, K. H., Green J. W., Gillies, P. J., Reynolds, J. L., Leonard, R. C. (2007a). Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med 49:1086–1096.
  • Sakr, C. J., Leonard, R. C., Kreckmann, K. H., Slade, M. D., Cullen, M. R. (2007b). Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49:872–879.
  • Sakr, C. J., Symons, J. M., Kreckmann, K. H., Leonard, R. C. (2009). Ischemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate. Occup Environ Med 66:699–703.
  • Scott, B. F., Spencer, C., Mabury, S. A., Muir, D. C. (2006). Poly- and perfluorinated carboxylates in North American precipitation. Environ Sci Technol 40:7167–7174.
  • Sibinski, L. J. (1987). Two-year oral (diet) toxicity/oncogenicity study of fluorochemical FC-143 in rats. Riker Experiment No. 0281CR0012, Riker Laboratories Inc/3M Company.
  • Spliethoff, H. M., Tao, L., Shaver, S. M., Aldous, K. M., Pass, K. A., Kannan, K., et al. (2008). Use of newborn screening program blood spots for exposure assessment: declining levels of perfluorinated compounds in New York state infants. Environ Sci Technol 42:5361–5367.
  • Stevens, J. T., Breckenridge, C. B., Wetzel, L. T., Gillis, J. H., Luempert, L. G., III. (1994). Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. J Toxicol Environ Health 43:139–163.
  • Sykes, G. (1987). Two-year toxicity/carcinogenicity study of fluorochemical FC-143 in rats. US EPA Administrative Record 226–1917.
  • Tan, Y. S., Yang, C., Harkema, J., Haslam, S. Z. (2009). Differential effect of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod Toxicol 27:425–426.
  • Tomy, G. T., Budakowski, W., Halldorson, T., Helm, P. A., Stern, G. A., Friesen, K., et al. (2004). Fluorinated organic compounds in an eastern Arctic marine food web. Environ Sci Technol 38:6475–6485.
  • US EPA. (2005). Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid and its salts. US Environmental Protection Agency, Office of Pollution Prevention and Toxics, Risk Assessment Division, Washington, DC, January 4, 2005.
  • White, S. S., Calafat, A. M., Kuklenyik, Z., Villanueva, L., Zehr, R. D., Helfant, L., et al. (2007). Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96:133–144.
  • White, S. S., Kato, K., Jia, L. T., Basden, B. J., Calafat, A. M., Hines, E. P., et al. (2009). Effects of perfluorooctanoic acid on mouse mammary gland development and the differentiation resulting from cross-foster and restricted gestational exposure. Reprod Toxicol 27:289–298.
  • Yamashita, N., Kannan, K., Taniyasu, S., Horii, Y., Petrick, G., Gamo, T. (2005). A global survey of perfluorinated acids in oceans. Mar Pollut Bull 51:658–668.
  • Yang, C., Tan, Y. S., Harkema, J., Haslam, S. Z. (2009). Differential effect of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod Toxicol 27:299–306.
  • Yang, Q., Reiko, K., Yamada, A., Kimura, S., Gonzalez, F. J. (2006). Peroxisome proliferator-activated receptor alpha activation during pregnancy severely impairs mammary lobuloalveolar development in mice. Endocrinology 147:4772–4780.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.